CHMP Advises Against Approval for Eteplirsen in DMD CHMP Advises Against Approval for Eteplirsen in DMD

The EMA ' s Committee for Medicinal Products for Human Use recommends against approval of eteplirsen for Duchenne muscular dystrophy but extends approval of ataluren to younger patients with the disease.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news